华润双鹤

600062 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

19.4B ($2.8B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

11.0B

Net Income

1.7B

Gross Margin

N/A

Op. Margin

16.9%

Net Margin

15.3%

ROE

13.5%

ROA

9.9%

D/E

0.36

Dividend Yield

N/A

EPS

1.59

Current Ratio

2.35

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2025

Business Overview

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 华润双鹤

Ticker	600062
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业